British Psychedelic Drug Firm Eleusis Plans $450 Million SPAC Deal

Eleusis is going public through a merger with a blank-check firm, according to people with knowledge of the matter.

The U.K.-based company will combine with Silver Spike Acquisition Corp. II in a deal that values Eleusis at about $450 million.